NPCE
insider transactionsNeuroPace Inc — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
5.4K sh
Own New
-
Grant·A
Director
$0
2.9K sh
Own New
-
Grant·A
Director
$0
5.4K sh
Own New
-
Grant·A
Director
$0
2.9K sh
Own +15%
-
Grant·A
Director
$0
5.4K sh
Own New
-
Grant·A
Director
$0
2.9K sh
Own +19%
-
Grant·A
Director
$0
5.4K sh
Own New
-
Grant·A
Director
$0
2.9K sh
Own +0%
-
Grant·A
Director
$0
5.4K sh
Own New
-
Grant·A
Director
$0
2.9K sh
Own New
-
Other·F
Joel Becker KEY
CHIEF EXECUTIVE OFFICER
$19.9K
1.3K sh · $15.88
Own -1%
-
Other·F
CHIEF MEDICAL OFFICER
$6.1K
358 sh · $17.06
Own -1%
-
Other·F
Joel Becker KEY
CHIEF EXECUTIVE OFFICER
$19.2K
1.1K sh · $17.06
Own -1%
-
Grant·A
Chief Financial Officer
$0
44.8K sh
Own New
-
Grant·A
Chief Financial Officer
$0
16.8K sh
Own +32%
-
Grant·A
CHIEF MEDICAL OFFICER
$0
14.6K sh
Own New
-
Grant·A
CHIEF MEDICAL OFFICER
$0
5.5K sh
Own +12%
-
Grant·A
Joel Becker KEY
CHIEF EXECUTIVE OFFICER
$0
122.2K sh
Own New
-
Grant·A
Joel Becker KEY
CHIEF EXECUTIVE OFFICER
$0
45.9K sh
Own +47%
-
Other·F
CHIEF MEDICAL OFFICER
$17.8K
1.3K sh · $13.27
Own -3%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 5, 2026 | Renee Ryan | Grant A | 5.4K | $0 |
| Jun 5, 2026 | Renee Ryan | Grant A | 2.9K | $0 |
| Jun 5, 2026 | Rakhi Kumar | Grant A | 5.4K | $0 |
| Jun 5, 2026 | Rakhi Kumar | Grant A | 2.9K | $0 |
| Jun 5, 2026 | Uri Geiger | Grant A | 5.4K | $0 |
| Jun 5, 2026 | Uri Geiger | Grant A | 2.9K | $0 |
| Jun 5, 2026 | Frank M Fischer | Grant A | 5.4K | $0 |
| Jun 5, 2026 | Frank M Fischer | Grant A | 2.9K | $0 |
| Jun 5, 2026 | Lisa Andrade | Grant A | 5.4K | $0 |
| Jun 5, 2026 | Lisa Andrade | Grant A | 2.9K | $0 |
| Jun 3, 2026 | Joel Becker KEY | Other F | 1.3K | $19.9K |
| May 27, 2026 | Martha Morrell | Other F | 358 | $6.1K |
| May 27, 2026 | Joel Becker KEY | Other F | 1.1K | $19.2K |
| May 15, 2026 | Patrick F. Williams KEY | Grant A | 44.8K | $0 |
| May 15, 2026 | Patrick F. Williams KEY | Grant A | 16.8K | $0 |
| May 15, 2026 | Martha Morrell | Grant A | 14.6K | $0 |
| May 15, 2026 | Martha Morrell | Grant A | 5.5K | $0 |
| May 15, 2026 | Joel Becker KEY | Grant A | 122.2K | $0 |
| May 15, 2026 | Joel Becker KEY | Grant A | 45.9K | $0 |
| Mar 24, 2026 | Martha Morrell | Other F | 1.3K | $17.8K |
About NPCE insider trading
This page tracks insider transactions for NeuroPace Inc (NPCE) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.